By
AmyT on
November 13, 2009
Today, just a sampling of some of the interesting stuff presented at last week’s Diabetes Technology Society meeting, that will be out on the market in … um… some years from now (?):
IN-105 Oral Insulin for Type 2 diabetes – Biocon Limited, apparently India’s premier biotechnology company, has been developing oral insulin tablets for some years now. Positive research results were announced last year. And they’re not just for basal use, either. Studies confirmed…
Read more »
By
AmyT on
November 12, 2009
The Diabetes Technology Society held its annual meeting last Thursday through Saturday, which always takes place just about a mile and a half from my house. But guess what? This was the very first year that I found myself on the inside of this exclusive event, participating in a panel (the very last panel of the 3-day event) on “technologies to drive patient adherence.”
The term “adherence” made me bristle, too, because it sounds like…
Read more »
By
AmyT on
October 1, 2009
Welcome to Part 2 of my talk with award-winning journalist and Type 1 diabetic Dan Hurley, whose new “epic book” Diabetes Rising is due out soon. In case you missed it, read Part 1 of the interview here. Today, Dan talks about achieving the impossible — an artificial pancreas that works, and a diabetes community that will band together to demand faster, better treatment advances.
DiabetesMine) While working on this book, what did you…
Read more »
By
AmyT on
September 29, 2009
Dan Hurley is a journalist and science writer who contributes regularly to the New York Times. He’s also written for the Medical Tribune and Psychology Today. And he’s one of us PWDs. His new book, Diabetes Rising, is an exposé on the academic world of diabetes, coming out January. Have a look at last week’s ‘Sneak Preview’ of the book.
When I talked with Dan recently, he had so much good stuff to share that…
Read more »
By
AmyT on
August 10, 2009
Francine Kaufman is one of the most recognized individuals in the field of diabetes care. She’s a world-renown pediatric endocrinologist at USC, a former ADA president, the author of Diabesity. Late last year, she made the leap to industry, joining Medtronic to become “a key architect of the company’s global diabetes strategy.” Today we’re privileged to hear her thoughts on then, now, and why:
A Guest Post by Dr. Francine Kaufman, Chief Medical Officer, Medtronic…
Read more »
